Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05145309
PHASE2

Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans

Sponsor: University of Texas Southwestern Medical Center

View on ClinicalTrials.gov

Summary

In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension, particularly in African Americans (AA). Key components of such a diet are potassium, magnesium, and alkali, each of which has been implicated in lowering blood pressure. In the original IND 116,208, the investigators explored whether potassium-magnesium citrate (KMgCit) as a powder pharmaceutical formulation (dissolved in water before ingestion) could serve as a surrogate for the DASH diet and would lower blood pressure among patients with pre- or Stage I hypertension. Unfortunately, previous studies did not include adequate number of African American patients.

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2026-11-15

Completion Date

2032-12-01

Last Updated

2025-12-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

KMgCit

Supplement that provide K, Mg, and citrate

DRUG

Placebo

Power with identical appearance to KMgCit

Locations (1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States